Net Cash Provided by (Used in) Operating Activities |
-1.87M |
USD |
+69.9% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
0 |
USD |
-100% |
Q1 2022 |
Q1 2022 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
-100% |
Q1 2022 |
Q1 2022 |
Common Stock, Shares Authorized |
20M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
2.71M |
shares |
+12.6% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-1.88M |
USD |
+69.8% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
4.59M |
USD |
-18.7% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Valuation Allowance |
82.4M |
USD |
+0.5% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
82.4M |
USD |
-0.71% |
Q4 2023 |
FY 2023 |
Property, Plant and Equipment, Gross |
126K |
USD |
-94.2% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
48.5M |
USD |
+3.09% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2022 |
Q3 2023 |
Preferred Stock, Shares Authorized |
500K |
shares |
0% |
Q2 2024 |
Q2 2024 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2022 |
Q3 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Share-based Payment Arrangement, Expense |
627K |
USD |
-82.5% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2024 |
Q2 2024 |